Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2022-01-20 00:00:00 ET · period of report 2022-01-18 · accession 0001104659-22-005976 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-20 | 2022-01-18 | PTCT | Utter Christine Marie | SVP, CAO, Fin | M - OptEx | $18.01 | +10.0K | 36.4K | +38% | +$180.1K |
| DM | 2022-01-20 | 2022-01-18 | PTCT | Utter Christine Marie | SVP, CAO, Fin | S - Sale+OE | $43.94 | -11.4K | 26.4K | -30% | -$502.1K |
| D | 2022-01-20 | 2022-01-18 | PTCT | Utter Christine Marie | SVP, CAO, Fin | M - OptEx | $18.01 | -10.0K | 0 | -100% | -$180.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-18 | M | A | 10,000 | $18.01 | 36,425 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-18 | S | D | 1,428 | $43.50 | 26,425 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-18 | S | D | 10,000 | $44.00 | 26,425 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-01-18 | M | D | 10,000 | $18.01 | 0 | D | $18.01 · — to 2028-01-02 | 10,000 Common Stock | (F2) Currently exercisable. |